Willy A. Noort

Amsterdam, NH 1081HV, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Humanized Bone Model Identifies BMP6 as a Multifunctional Regulator in Myeloma Bone Disease.

Humanized Bone Model Identifies BMP6 as a Multifunctional Regulator in Myeloma Bone Disease.

Journal: Biomolecules

Published: October 31, 2025

Oncogene EVI1 drives acute myeloid leukemia via a targetable interaction with CTBP2.

Oncogene EVI1 drives acute myeloid leukemia via a targetable interaction with CTBP2.

Journal: Science advances

Published: May 15, 2024

Isolation of Pig Bone Marrow-Derived Mesenchymal Stem Cells.

Isolation of Pig Bone Marrow-Derived Mesenchymal Stem Cells.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: May 30, 2016

Establishing human leukemia xenograft mouse models by implanting human bone marrow-like scaffold-based niches.

Establishing human leukemia xenograft mouse models by implanting human bone marrow-like scaffold-based niches.

Journal: Blood

Published: May 26, 2016

Sepantronium bromide (YM155) improves daratumumab-mediated cellular lysis of multiple myeloma cells by abrogation of bone marrow stromal cell-induced resistance.

Sepantronium bromide (YM155) improves daratumumab-mediated cellular lysis of multiple myeloma cells by abrogation of bone marrow stromal cell-induced resistance.

Journal: Haematologica

Published: May 07, 2016

Pre-clinical evaluation of CD38 chimeric antigen receptor engineered T cells for the treatment of multiple myeloma.

Pre-clinical evaluation of CD38 chimeric antigen receptor engineered T cells for the treatment of multiple myeloma.

Journal: Haematologica

Published: October 06, 2015

Optimal selection of natural killer cells to kill myeloma: the role of HLA-E and NKG2A.

Optimal selection of natural killer cells to kill myeloma: the role of HLA-E and NKG2A.

Journal: Cancer immunology, immunotherapy : CII

Published: September 17, 2014

Preclinical Evidence for the Therapeutic Potential of CD38-Targeted Immuno-Chemotherapy in Multiple Myeloma Patients Refractory to Lenalidomide and Bortezomib.

Preclinical Evidence for the Therapeutic Potential of CD38-Targeted Immuno-Chemotherapy in Multiple Myeloma Patients Refractory to Lenalidomide and Bortezomib.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: July 14, 2014

Increasing short-term cardiomyocyte progenitor cell (CMPC) survival by necrostatin-1 did not further preserve cardiac function.

Increasing short-term cardiomyocyte progenitor cell (CMPC) survival by necrostatin-1 did not further preserve cardiac function.

Journal: Cardiovascular research

Published: April 05, 2013

Reconstructing the human hematopoietic niche in immunodeficient mice: opportunities for studying primary multiple myeloma.

Reconstructing the human hematopoietic niche in immunodeficient mice: opportunities for studying primary multiple myeloma.

Journal: Blood

Published: June 02, 2012

Showing 1-10 of 10

Last Updated: 09/26/2026